ArticleJournal of translational medicine2017

Identification of coexistence of BRAF V600E mutation and EZH2 gain specifically in melanoma as a promising target for combination therapy.

Huan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.